Form 8-K - Current report:
SEC Accession No. 0001213900-24-087764
Filing Date
2024-10-15
Accepted
2024-10-15 15:54:52
Documents
16
Period of Report
2024-10-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0217601-8k_incannex.htm   iXBRL 8-K 29501
2 FORM OF FACILITY AGREEMENT BETWEEN INCANNEX HEALTHCARE PTY LTD, INCANNEX PTY LTD ea021760101ex10-1_incannex.htm EX-10.1 608777
3 GRAPHIC ex10-1_001.jpg GRAPHIC 3940
4 GRAPHIC ex10-1_002.jpg GRAPHIC 6821
  Complete submission text file 0001213900-24-087764.txt   909214

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE ixhl-20241009.xsd EX-101.SCH 3024
6 XBRL LABEL FILE ixhl-20241009_lab.xml EX-101.LAB 34240
7 XBRL PRESENTATION FILE ixhl-20241009_pre.xml EX-101.PRE 22365
18 EXTRACTED XBRL INSTANCE DOCUMENT ea0217601-8k_incannex_htm.xml XML 3787
Mailing Address 401 DOCKLANDS DRIVE SUITE 15, LEVEL 12 DOCKLANDS, VICTORIA C3 3008
Business Address 401 DOCKLANDS DRIVE SUITE 15, LEVEL 12 DOCKLANDS, VICTORIA C3 3008 61 409 840 786
Incannex Healthcare Inc. (Filer) CIK: 0001873875 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-41106 | Film No.: 241371753
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)